Does pancreatic exocrine insufficiency reduce fat and omega-3 absorption?

Pancreatic exocrine insufficiency (PEI) is characterized by a critical deficiency in the secretion of pancreatic digestive enzymes, which directly compromises the body's ability to process and absorb essential dietary lipids.

Fat malabsorption and clinical evidence

• Impaired lipid digestion: Normal adults absorb 92% to 93% of dietary fat, but in PEI, the coefficient of fat absorption (CFA) frequently drops below 80% to 85%. This leads to over 7 grams of fecal fat excretion per day.
• Clinical consequences: Patients often present with steatorrhea, progressive weight loss, and deficiencies in fat-soluble vitamins (A, D, E, and K). Diagnostic markers typically show low fecal elastase-1 levels (<200 µg/g).

Mechanistic explanations

• Lipase deficiency: PEI severely reduces intraluminal pancreatic lipase and its cofactor, colipase. This halts the hydrolysis of triglycerides, preventing micelle formation.
• Omega-3 vulnerability: Long-chain polyunsaturated fatty acids like EPA and DHA require pancreatic lipase to hydrolyze their triglyceride or ethyl ester bonds. Without sufficient lipase, these essential fatty acids remain unabsorbed. However, free carboxylic acid formulations of omega-3s can bypass this lipase dependency.

Therapeutic mitigation

• Role of PERT: Pancreatic enzyme replacement therapy (PERT) delivers exogenous lipase, which has been shown in preclinical models to increase the absorption and plasma uptake of EPA and DHA by 51% to 89%.
• Residual deficits: Although PERT significantly improves omega-3 incorporation into plasma and erythrocyte membranes, absorption efficiency in PEI patients may still not fully reach normal physiological levels.

Bottom line

• Bottom line: Pancreatic exocrine insufficiency directly impairs the digestion of dietary fats and limits the absorption of long-chain omega-3 fatty acids (EPA and DHA) due to a pancreatic lipase deficit. While pancreatic enzyme replacement therapy (PERT) drastically improves lipid uptake and omega-3 absorption, overall efficiency may still remain below healthy baseline levels.